Skip to main content

Table 1 Patient demographics included in this study

From: Diffusion-weighted MR imaging diagnostic merits in the post-therapeutic assessment of musculoskeletal soft tissue sarcoma

Types of soft tissue sarcomas included in the study
  Pathology Number of cases Percentage
Synovial sarcoma 10 27.77%
Rhabomyosacroma RMS 9 24.9%
Malignant peripheral nerve sheath tumor MPNT 2 5.55 %
Liposarcoma 4 11.1%
Leimyosarcoma 2 5.55%
Myofibroblastic Sarcoma 2 5.55%
Fibrosarcoma 2 5.55%
Undifferentiated sarcoma 3 8.3%
Round cell tumor 2 5.55 %
Post-operative pathology
7 patients Optimal response Suboptimal response No comment on degree of necrosis and tumor viability
  3 2 2
Site of the primary tumor
Location Lower extremity Upper extremity Trunk
  25/36 6/36 2/36
Treatment plan
Treatment Chemotherapy Concomitant chemo-radiotherapy (CCRTH) Surgery following chemotherapy
  28/36 (77.7%) 8/36 (22.2 %) 7/36 (19.4%)
The interval between initial baseline MRI study and the follow-up MRI exams Ranging from 1 month up to 1-year post-therapy, with an average of about 4.5 months duration of follow up